These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 38099302)

  • 41. Compound-protein interaction prediction with end-to-end learning of neural networks for graphs and sequences.
    Tsubaki M; Tomii K; Sese J
    Bioinformatics; 2019 Jan; 35(2):309-318. PubMed ID: 29982330
    [TBL] [Abstract][Full Text] [Related]  

  • 42. GSL-DTI: Graph structure learning network for Drug-Target interaction prediction.
    E Z; Qiao G; Wang G; Li Y
    Methods; 2024 Mar; 223():136-145. PubMed ID: 38360082
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TransVAE-DTA: Transformer and variational autoencoder network for drug-target binding affinity prediction.
    Zhou C; Li Z; Song J; Xiang W
    Comput Methods Programs Biomed; 2024 Feb; 244():108003. PubMed ID: 38181572
    [TBL] [Abstract][Full Text] [Related]  

  • 44. GEFA: Early Fusion Approach in Drug-Target Affinity Prediction.
    Nguyen TM; Nguyen T; Le TM; Tran T
    IEEE/ACM Trans Comput Biol Bioinform; 2022; 19(2):718-728. PubMed ID: 34197324
    [TBL] [Abstract][Full Text] [Related]  

  • 45. GraphormerDTI: A graph transformer-based approach for drug-target interaction prediction.
    Gao M; Zhang D; Chen Y; Zhang Y; Wang Z; Wang X; Li S; Guo Y; Webb GI; Nguyen ATN; May L; Song J
    Comput Biol Med; 2024 May; 173():108339. PubMed ID: 38547658
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drug-target binding affinity prediction using message passing neural network and self supervised learning.
    Xia L; Xu L; Pan S; Niu D; Zhang B; Li Z
    BMC Genomics; 2023 Sep; 24(1):557. PubMed ID: 37730555
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of a graph convolutional neural network model for efficient prediction of protein-ligand binding affinities.
    Son J; Kim D
    PLoS One; 2021; 16(4):e0249404. PubMed ID: 33831016
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NG-DTA: Drug-target affinity prediction with n-gram molecular graphs.
    Tsui LI; Hsu TC; Lin C
    Annu Int Conf IEEE Eng Med Biol Soc; 2023 Jul; 2023():1-4. PubMed ID: 38082648
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MDF-DTA: A Multi-Dimensional Fusion Approach for Drug-Target Binding Affinity Prediction.
    Ranjan A; Bess A; Alvin C; Mukhopadhyay S
    J Chem Inf Model; 2024 Jul; 64(13):4980-4990. PubMed ID: 38888163
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identifying drug-target interactions based on graph convolutional network and deep neural network.
    Zhao T; Hu Y; Valsdottir LR; Zang T; Peng J
    Brief Bioinform; 2021 Mar; 22(2):2141-2150. PubMed ID: 32367110
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modality-DTA: Multimodality Fusion Strategy for Drug-Target Affinity Prediction.
    Yang X; Niu Z; Liu Y; Song B; Lu W; Zeng L; Zeng X
    IEEE/ACM Trans Comput Biol Bioinform; 2023; 20(2):1200-1210. PubMed ID: 36083952
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhancing generalizability and performance in drug-target interaction identification by integrating pharmacophore and pre-trained models.
    Zhang Z; He X; Long D; Luo G; Chen S
    Bioinformatics; 2024 Jun; 40(Suppl 1):i539-i547. PubMed ID: 38940179
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MultiscaleDTA: A multiscale-based method with a self-attention mechanism for drug-target binding affinity prediction.
    Chen H; Li D; Liao J; Wei L; Wei L
    Methods; 2022 Nov; 207():103-109. PubMed ID: 36155250
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Breaking the barriers of data scarcity in drug-target affinity prediction.
    Pei Q; Wu L; Zhu J; Xia Y; Xie S; Qin T; Liu H; Liu TY; Yan R
    Brief Bioinform; 2023 Sep; 24(6):. PubMed ID: 37903413
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TEC-miTarget: enhancing microRNA target prediction based on deep learning of ribonucleic acid sequences.
    Yang T; Wang Y; He Y
    BMC Bioinformatics; 2024 Apr; 25(1):159. PubMed ID: 38643080
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Biological Feature and Heterogeneous Network Representation Learning-Based Framework for Drug-Target Interaction Prediction.
    Liu L; Zhang Q; Wei Y; Zhao Q; Liao B
    Molecules; 2023 Sep; 28(18):. PubMed ID: 37764321
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drug-target Affinity Prediction by Molecule Secondary Structure Representation Network.
    Tang Y; Li Y; Li P; Liu ZP
    Curr Med Chem; 2024 Feb; ():. PubMed ID: 38409701
    [TBL] [Abstract][Full Text] [Related]  

  • 58. BACPI: a bi-directional attention neural network for compound-protein interaction and binding affinity prediction.
    Li M; Lu Z; Wu Y; Li Y
    Bioinformatics; 2022 Mar; 38(7):1995-2002. PubMed ID: 35043942
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CMMS-GCL: cross-modality metabolic stability prediction with graph contrastive learning.
    Du BX; Long Y; Li X; Wu M; Shi JY
    Bioinformatics; 2023 Aug; 39(8):. PubMed ID: 37572298
    [TBL] [Abstract][Full Text] [Related]  

  • 60. GraphATT-DTA: Attention-Based Novel Representation of Interaction to Predict Drug-Target Binding Affinity.
    Bae H; Nam H
    Biomedicines; 2022 Dec; 11(1):. PubMed ID: 36672575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.